Trulieve Cannabis Corp.
TRUL.CNCNQHealthcare● Active
$18.15
+$1.70(+10.33%)
Market Cap$3.1B
P/E Ratio—
52W High$18.15
52W Low$4.45
Trulieve Cannabis Corp. (TRUL.CN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TRUL.CN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.01
Est. -$0.02 · +170.8%
Revenue
$0.40B
Est. $0.40B · +0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
TRUL.CN reports quarterly as a CNQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.00B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.05 | — | — | — | $0.41B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.02 | $0.01 | +170.8% | $0.40B | $0.40B | +0.7% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.10 | -$0.30 | -196.2% | $0.40B | $0.41B | -1.8% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -$0.07 | -$0.10 | -46.5% | $0.41B | $0.29B | +43.3% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.08 | -$0.17 | -112.5% | $0.30B | $0.30B | -1.9% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.24 | -$0.27 | -12.5% | $0.43B | $0.29B | +48.1% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -$0.13 | -$0.33 | -153.8% | $0.39B | $0.29B | +31.9% |
| ▲ Q3 FY2024 | Aug 6, 2024 | -$0.08 | -$0.06 | +25.0% | $0.41B | $0.41B | +2.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.01
EPS Est.
-$0.02
EPS Surpr.
+170.8%
Revenue
$0.40B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.30
EPS Est.
-$0.10
EPS Surpr.
-196.2%
Revenue
$0.40B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.07
EPS Surpr.
-46.5%
Revenue
$0.41B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.08
EPS Surpr.
-112.5%
Revenue
$0.30B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.24
EPS Surpr.
-12.5%
Revenue
$0.43B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
-$0.33
EPS Est.
-$0.13
EPS Surpr.
-153.8%
Revenue
$0.39B
Q3 FY2024
Aug 6, 2024Beat
EPS Actual
-$0.06
EPS Est.
-$0.08
EPS Surpr.
+25.0%
Revenue
$0.41B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q1 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2026 | $0.03 | $0.03 | $0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2026 | $0.3B | $0.3B | $0.3B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +170.8% | $13.48 | $12.67 | -6.01% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -196.2% | $8.74 | $8.89 | +1.72% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -46.5% | $7.45 | $7.28 | -2.28% |
| ▼ Q2 FY2025 | May 7, 2025 | -112.5% | $6.23 | $6.13 | -1.61% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -12.5% | $5.89 | $5.94 | +0.85% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -153.8% | $17.63 | $16.15 | -8.39% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +25.0% | $12.77 | $13.49 | +5.64% |
| ▼ Q2 FY2024 | May 9, 2024 | -20.0% | $14.91 | $15.97 | +7.11% |
Q2 FY2026-6.01%
Report Date
May 7, 2026
EPS Beat/Miss
+170.8%
Price Before
$13.48
Price After
$12.67
Q1 FY2026+1.72%
Report Date
Feb 26, 2026
EPS Beat/Miss
-196.2%
Price Before
$8.74
Price After
$8.89
Q3 FY2025-2.28%
Report Date
Aug 6, 2025
EPS Beat/Miss
-46.5%
Price Before
$7.45
Price After
$7.28
Q2 FY2025-1.61%
Report Date
May 7, 2025
EPS Beat/Miss
-112.5%
Price Before
$6.23
Price After
$6.13
Q1 FY2025+0.85%
Report Date
Feb 26, 2025
EPS Beat/Miss
-12.5%
Price Before
$5.89
Price After
$5.94
Q4 FY2024-8.39%
Report Date
Nov 5, 2024
EPS Beat/Miss
-153.8%
Price Before
$17.63
Price After
$16.15
Q3 FY2024+5.64%
Report Date
Aug 6, 2024
EPS Beat/Miss
+25.0%
Price Before
$12.77
Price After
$13.49
Q2 FY2024+7.11%
Report Date
May 9, 2024
EPS Beat/Miss
-20.0%
Price Before
$14.91
Price After
$15.97
Avg Beat Reaction-0.19%
Avg Miss Reaction-0.43%
Beat Rate2 / 8 quarters
Largest Move-8.39% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TRUL.CN ends December
Trulieve Cannabis Corp. (TRUL.CN) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.01 — beating the analyst consensus of $-0.02 by +170.8%. The next TRUL.CN earnings date is expected around September 1, 2026.
Each quarter, investors track TRUL.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TRUL.CN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TRUL.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TRUL.CN earnings · 5 questionsTrulieve Cannabis Corp.'s next earnings report is expected around September 1, 2026. TRUL.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TRUL.CN historically reports after market close (AMC).
TRUL.CN earnings datewhen is TRUL.CN earningsTRUL.CN next earnings datewhen does TRUL.CN report earningsTRUL.CN earnings calendar
▸ Source: FMP · Trulieve Cannabis Corp. SEC filings · US GAAP · Trulieve Cannabis Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026